BUENA, N.J., Nov. 13, 2013 /PRNewswire/ -- IGI Laboratories,
Inc. (NYSE Amex: IG), a New Jersey
based generic topical pharmaceutical company will be presenting at
the Oppenheimer 24th Annual Healthcare Conference. The
Conference will take place on December 10 -
11, 2013 at the Crowne Plaza Hotel in New York, New York.
(Logo:
http://photos.prnewswire.com/prnh/20130827/MM70487LOGO)
Jason Grenfell-Gardner, President
and CEO and Jenniffer Collins, Chief
Financial Officer of IGI Laboratories, Inc. will present on
Tuesday December 10, 2013, at
4:30 PM ET. Investors attending
the conferences who wish to meet with Mr. Grenfell-Gardner and Mrs.
Collins for a one-on-one meeting should contact their Oppenheimer
representative or the Company.
The replay of the presentation will be webcast and will be
available for 90 days online on the Investors section of the
Company's website at http://www.igilabs.com.
About IGI Laboratories, Inc.
IGI Laboratories is a generic topical pharmaceutical
company. We develop and manufacture topical formulations for
the pharmaceutical, OTC, and cosmetic markets. Our mission is to be
a leader in the generic topical prescription drug market.
SOURCE IGI Laboratories, Inc.